Phase IB trial of high dose ascorbic acid + nab-paclitaxel + cisplatin + gemcitabine in patients with untreated metastatic pancreatic cancer.
Saved in:
| Title: | Phase IB trial of high dose ascorbic acid + nab-paclitaxel + cisplatin + gemcitabine in patients with untreated metastatic pancreatic cancer. |
|---|---|
| Authors: | Jameson GS; HonorHealth Research Institute, Scottsdale, AZ, USA. Electronic address: gjameson@HonorHealth.com., LeGrand SD; HonorHealth Research Institute, Scottsdale, AZ, USA., Gordon MS; HonorHealth Research Institute, Scottsdale, AZ, USA; Translational Genomics Research Institute (TGen), Part of City of Hope, Phoenix, AZ, USA., Roe DJ; The University of Arizona Cancer Center, Tucson, AZ, USA., Wertheim BC; The University of Arizona Cancer Center, Tucson, AZ, USA., Olszewski K; Ludwig Institute for Cancer Research, Princeton Branch, Princeton University, Princeton, NJ, USA., Rabinowitz J; Ludwig Institute for Cancer Research, Princeton Branch, Princeton University, Princeton, NJ, USA., Evans R; Salk Institute, La Jolla, CA, USA., Downes M; Salk Institute, La Jolla, CA, USA., Truitt M; Salk Institute, La Jolla, CA, USA., Korn R; Imaging Endpoints, Scottsdale, AZ, USA., Han H; Translational Genomics Research Institute (TGen), Part of City of Hope, Phoenix, AZ, USA., Miller RM; HonorHealth Research Institute, Scottsdale, AZ, USA., Barrett MT; Mayo Clinic, Scottsdale, AZ, USA., Propper D; Barts Cancer Institute, Queen Mary University of London, London, UK., Von Hoff DD; HonorHealth Research Institute, Scottsdale, AZ, USA; Translational Genomics Research Institute (TGen), Part of City of Hope, Phoenix, AZ, USA., Borazanci E; HonorHealth Research Institute, Scottsdale, AZ, USA. |
| Source: | Redox biology [Redox Biol] 2025 Dec; Vol. 88, pp. 103895. Date of Electronic Publication: 2025 Oct 25. |
| Publication Type: | Journal Article; Clinical Trial, Phase I; Research Support, Non-U.S. Gov't; Research Support, N.I.H., Extramural |
| Journal Info: | Publisher: Elsevier, B.V Country of Publication: Netherlands NLM ID: 101605639 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 2213-2317 (Electronic) Linking ISSN: 22132317 NLM ISO Abbreviation: Redox Biol Subsets: MEDLINE |
| Database: | MEDLINE Ultimate |
| FullText | Text: Availability: 0 |
|---|---|
| Header | DbId: mdl DbLabel: MEDLINE Ultimate An: 41197185 AccessLevel: 2 PubType: Academic Journal PubTypeId: academicJournal PreciseRelevancyScore: 0 |
| IllustrationInfo | |
| Items | – Name: Title Label: Title Group: Ti Data: Phase IB trial of high dose ascorbic acid + nab-paclitaxel + cisplatin + gemcitabine in patients with untreated metastatic pancreatic cancer. – Name: Author Label: Authors Group: Au Data: <searchLink fieldCode="AU" term="%22Jameson+GS%22">Jameson GS</searchLink>; HonorHealth Research Institute, Scottsdale, AZ, USA. Electronic address: gjameson@HonorHealth.com.<br /><searchLink fieldCode="AU" term="%22LeGrand+SD%22">LeGrand SD</searchLink>; HonorHealth Research Institute, Scottsdale, AZ, USA.<br /><searchLink fieldCode="AU" term="%22Gordon+MS%22">Gordon MS</searchLink>; HonorHealth Research Institute, Scottsdale, AZ, USA; Translational Genomics Research Institute (TGen), Part of City of Hope, Phoenix, AZ, USA.<br /><searchLink fieldCode="AU" term="%22Roe+DJ%22">Roe DJ</searchLink>; The University of Arizona Cancer Center, Tucson, AZ, USA.<br /><searchLink fieldCode="AU" term="%22Wertheim+BC%22">Wertheim BC</searchLink>; The University of Arizona Cancer Center, Tucson, AZ, USA.<br /><searchLink fieldCode="AU" term="%22Olszewski+K%22">Olszewski K</searchLink>; Ludwig Institute for Cancer Research, Princeton Branch, Princeton University, Princeton, NJ, USA.<br /><searchLink fieldCode="AU" term="%22Rabinowitz+J%22">Rabinowitz J</searchLink>; Ludwig Institute for Cancer Research, Princeton Branch, Princeton University, Princeton, NJ, USA.<br /><searchLink fieldCode="AU" term="%22Evans+R%22">Evans R</searchLink>; Salk Institute, La Jolla, CA, USA.<br /><searchLink fieldCode="AU" term="%22Downes+M%22">Downes M</searchLink>; Salk Institute, La Jolla, CA, USA.<br /><searchLink fieldCode="AU" term="%22Truitt+M%22">Truitt M</searchLink>; Salk Institute, La Jolla, CA, USA.<br /><searchLink fieldCode="AU" term="%22Korn+R%22">Korn R</searchLink>; Imaging Endpoints, Scottsdale, AZ, USA.<br /><searchLink fieldCode="AU" term="%22Han+H%22">Han H</searchLink>; Translational Genomics Research Institute (TGen), Part of City of Hope, Phoenix, AZ, USA.<br /><searchLink fieldCode="AU" term="%22Miller+RM%22">Miller RM</searchLink>; HonorHealth Research Institute, Scottsdale, AZ, USA.<br /><searchLink fieldCode="AU" term="%22Barrett+MT%22">Barrett MT</searchLink>; Mayo Clinic, Scottsdale, AZ, USA.<br /><searchLink fieldCode="AU" term="%22Propper+D%22">Propper D</searchLink>; Barts Cancer Institute, Queen Mary University of London, London, UK.<br /><searchLink fieldCode="AU" term="%22Von+Hoff+DD%22">Von Hoff DD</searchLink>; HonorHealth Research Institute, Scottsdale, AZ, USA; Translational Genomics Research Institute (TGen), Part of City of Hope, Phoenix, AZ, USA.<br /><searchLink fieldCode="AU" term="%22Borazanci+E%22">Borazanci E</searchLink>; HonorHealth Research Institute, Scottsdale, AZ, USA. – Name: TitleSource Label: Source Group: Src Data: <searchLink fieldCode="JN" term="%22101605639%22">Redox biology</searchLink> [Redox Biol] 2025 Dec; Vol. 88, pp. 103895. <i>Date of Electronic Publication: </i>2025 Oct 25. – Name: TypePub Label: Publication Type Group: TypPub Data: Journal Article; Clinical Trial, Phase I; Research Support, Non-U.S. Gov't; Research Support, N.I.H., Extramural – Name: TitleSource Label: Journal Info Group: Src Data: <i>Publisher: </i><searchLink fieldCode="PB" term="%22Elsevier%2C+B%2EV%22">Elsevier, B.V </searchLink><i>Country of Publication: </i>Netherlands <i>NLM ID: </i>101605639 <i>Publication Model: </i>Print-Electronic <i>Cited Medium: </i>Internet <i>ISSN: </i>2213-2317 (Electronic) <i>Linking ISSN: </i><searchLink fieldCode="IS" term="%2222132317%22">22132317 </searchLink><i>NLM ISO Abbreviation: </i>Redox Biol <i>Subsets: </i>MEDLINE |
| PLink | https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&db=mdl&AN=41197185 |
| RecordInfo | BibRecord: BibEntity: Identifiers: – Type: doi Value: 10.1016/j.redox.2025.103895 Languages: – Code: eng Text: English PhysicalDescription: Pagination: StartPage: 103895 Titles: – TitleFull: Phase IB trial of high dose ascorbic acid + nab-paclitaxel + cisplatin + gemcitabine in patients with untreated metastatic pancreatic cancer. Type: main BibRelationships: HasContributorRelationships: – PersonEntity: Name: NameFull: Jameson GS – PersonEntity: Name: NameFull: LeGrand SD – PersonEntity: Name: NameFull: Gordon MS – PersonEntity: Name: NameFull: Roe DJ – PersonEntity: Name: NameFull: Wertheim BC – PersonEntity: Name: NameFull: Olszewski K – PersonEntity: Name: NameFull: Rabinowitz J – PersonEntity: Name: NameFull: Evans R – PersonEntity: Name: NameFull: Downes M – PersonEntity: Name: NameFull: Truitt M – PersonEntity: Name: NameFull: Korn R – PersonEntity: Name: NameFull: Han H – PersonEntity: Name: NameFull: Miller RM – PersonEntity: Name: NameFull: Barrett MT – PersonEntity: Name: NameFull: Propper D – PersonEntity: Name: NameFull: Von Hoff DD – PersonEntity: Name: NameFull: Borazanci E IsPartOfRelationships: – BibEntity: Dates: – D: 01 M: 12 Text: 2025 Dec Type: published Y: 2025 Identifiers: – Type: issn-electronic Value: 2213-2317 Numbering: – Type: volume Value: 88 Titles: – TitleFull: Redox biology Type: main |
| ResultId | 1 |